President Donald Trump has ordered federal officials to scour monuments, memorials and statues to remove language he says may "inappropriately disparage Americans," as part of his efforts to fight ...

Petrenko V, Sinturel F, Riezman H, Dibner C. Lipid metabolism around the body clocks. Progress in lipid research ...

Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in ...

ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP-1 ... but their influence on collagen synthesis and skin elasticity remains underexplored. This literature review investigates the effects ...

Department of Plant Pathology and Nematology, University of São Paulo (USP)/Luiz de Queiroz College of Agriculture (ESALQ), Av. Pádua Dias, 11, Piracicaba, São Paulo 13418-900, Brazil Department of ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon. It has ...

Manufactured by Novo Nordisk, semaglutide is the newest in a family of glucagon-like peptide-1 receptor agonists used most commonly to treat type II diabetes. To date, the results of semaglutide for ...

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing β cells within pancreatic islets, the specialized endocrine cell clusters of the pancreas. Islet ...